NEW YORK, April 13 (GenomeWeb News) - Orchid BioSciences Europe will provide DNA testing services to the New Zealand immigration authorities, parent company Orchid BioSciences said today.
Under the three-year contract, which is potentially renewable for two years, Orchid will test DNA samples from applicants seeking residency in New Zealand to determine their biological relationships to family members.
Under New Zealand law, certain relatives of citizens and permanent residents are allowed to immigrate. DNA testing will be applied to applicants from countries with record systems that do not satisfy the requirements of the New Zealand Immigration Service.
Orchid BioSciences Europe, based in Abingdon, UK, already provides immigration DNA testing for the UK and Norway. The company resulted from Orchid's acquisition of Cellmark Diagnostics in 2001.